drugset / Trial / NCT03642288

The Use of Gastrografin in Chronic Radiation Enteropathy With Small Bowel Obstruction

NCT03642288

Unknown 112 enrolled Jinling Hospital, China
Non-randomizedParallel-groupTriple-blindTreatment

Summary

Chronic radiation enteropathy (CRE) is a major issue for long-term cancer survivors. The aim of this study was to clarify the diagnostic and therapeutic effect of the Gastrografin (GG) challenge for patients with CRE induced small bowel obstruction SBO.

Timeline

Start
2014-04-01
Primary completion
2018-06-30
Completion
2018-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Gastrografin Diagnostic / imaging agent

Indications

No indication recorded.